CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis

Human Immunology

Volumn 74, Issue 2, 2013, Pages 249-255

  Qiu, Zhi Xin ^a   Zhang, Kui ^b   Qiu, Xue Song ^c   Zhou, Min ^d   Li, Wei Min ^a,b,c,d  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Yubei District People's Hospital   (China)

^d Infectious Disease Control and Prevention Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD226 PROTEIN; GLYCINE; MEMBRANE PROTEIN; SERINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; DNA POLYMORPHISM; EMBASE; GENETIC MODEL; GRAVES DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; META ANALYSIS; MULTIPLE SCLEROSIS; PRIMARY SICCA SYNDROME; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; WEGENER GRANULOMATOSIS;

ALLELES; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INHERITANCE PATTERNS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84872609753     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.009     Document Type: Article

References (31)

1. Deshmukh H., Kim-Howard X., Nath S.K. Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in genetic analysis workshop 16 rheumatoid arthritis data. BMC Proc 2009, 3(Suppl 7):S31.
2. Lettre G., Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17(R2):R116-R121.
3. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39(7):857-864.
4. Hafler J.P., Maier L.M., Cooper J.D., Plagnol V., Hinks A., Simmonds M.J., et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009, 10(1):5-10.
5. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009, 10(6):591-595.
6. Dieude P., Guedj M., Truchetet M.E., Wipff J., Revillod L., Riemekasten G., et al. Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum 2011, 63(4):1097-1105.
7. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357(10):977-986.
8. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76(5):773-779.
9. Brand O.J., Lowe C.E., Heward J.M., Franklyn J.A., Cooper J.D., Todd J.A., et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol 2007, 66(4):508-512.
10. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357(9):851-862.
11. Weber F., Fontaine B., Cournu-Rebeix I., Kroner A., Knop M., Lutz S., et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 2008, 9(3):259-263.
12. Maiti A.K., Kim-Howard X., Viswanathan P., Guillen L., Qian X., Rojas-Villarraga A., et al. Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatology (Oxford) 2010, 49(7):1239-1244.
13. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127(9):820-826.
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
15. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
16. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
17. Alcina A., Vandenbroeck K., Otaegui D., Saiz A., Gonzalez J.R., Fernandez O., et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 2010, 11(5):439-445.
18. Douroudis K., Kisand K., Nemvalts V., Rajasalu T., Uibo R. Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population. BMC Med Genet 2010, 11:11.
19. Du Y., Tian L., Shen L.X., Wang F., Yu L.K., Song Y., et al. Association of the CD226 single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han population. Tissue Antigens 2011, 77(1):65-67.
20. Douroudis K., Nemvalts V., Rajasalu T., Kisand K., Uibo R. The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens 2009, 74(5):417-419.
21. Douroudis K., Kingo K., Silm H., Reimann E., Traks T., Vasar E., et al. The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. J Dermatol Sci 2010, 58(2):160-161.
22. Booth D.R., Heard R.N., Stewart G.J., Goris A., Dobosi R., Dubois B., et al. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009, 10(1):11-14.
23. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359(26):2767-2777.
24. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996, 4(6):573-581.
25. Dardalhon V., Schubart A.S., Reddy J., Meyers J.H., Monney L., Sabatos C.A., et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol 2005, 175(3):1558-1565.
26. Tao D., Shangwu L., Qun W., Yan L., Wei J., Junyan L., et al. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2005, 174(3):1281-1290.
27. Reymond N., Imbert A.M., Devilard E., Fabre S., Chabannon C., Xerri L., et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 2004, 199(10):1331-1341.
28. Komocsi A., Lamprecht P., Csernok E., Mueller A., Holl-Ulrich K., Seitzer U., et al. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 2002, 160(5):1717-1724.
29. Abdulahad W.H., Stegeman C.A., van der Geld Y.M., Doornbos-van der Meer B., Limburg P.C., Kallenberg C.G. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007, 56(6):2080-2091.
30. Abdulahad W.H., Stegeman C.A., Limburg P.C., Kallenberg C.G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58(7):2196-2205.
31. Capraru D., Muller A., Csernok E., Gross W.L., Holl-Ulrich K., Northfield J., et al. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol 2008, 127(2):144-150.